A new report from Transparency Market Research titled “Asthma and COPD Drug Market – Global Industry Analysis, Market Size, Share, Trends, Growth and Forecasts, 2010 – 2017” predicts an increase in the asthma and COPD drug market from ~25 billion in 2010 to ~27 billion in 2017. The report suggests that price erosion and the expiration of patents with few novel drugs on the horizon will lead to slow growth despite an increasing patient population.
According to Transparency, “The opportunities in the asthma and COPD market is [sic] huge as many companies are focusing on contract manufacturing outsourcing (CMO) and large players have entered this market with new product development. Increase in awareness about the benefits of timely diagnosis for asthma and COPD and availability of healthcare equipment for the detection of asthma and COPD in rural areas will further boost the market and growth opportunities for market players.”
Read the Transparency press release.
